1.Arizti-Sanz J, Bradley A, Zhang Y, Boehm C, Freije C, Grunberg M, Kosoko-Thoroddsen T-S, Welch N, Pillai P, Mantena S, Kim G, Uwanibe J, John O, Eromon P, Kocher G, Gross R, Lee J, Hensley L, MacInnis B, Johnson J, Springer M, Happi C, Sabeti P, Myhrvold C. Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants. Nat Biomed Eng. 2022;6(8):932–943. PMCID: PMC9398993 Reference Link
1.Welch N, Zhu M, Hua C, Weller J, Mirhashemi M, Nguyen T, Mantena S, Bauer M, Shaw B, Ackerman C, Thakku S, Tse M, Kehe J, Uwera M-M, Eversley J, Bielwaski D, McGrath G, Braidt J, Johnson J, Cerrato F, Moreno G, Krasilnikova L, Petros B, Gionet G, King E, Huard R, Jalbert S, Cleary M, Fitzgerald N, Gabriel S, Gallagher G, Smole S, Madoff L, Brown C, Keller M, Wilson M, Kirby M, Barnes J, Park D, Siddle K, Happi C, Hung D, Springer M, MacInnis B, Lemieux J, Rosenberg E, Branda J, Blainey P, Sabeti P, Myhrvold C. Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants. Nat Med. 2022;28(5):1083–1094. PMCID: PMC9117129 Reference Link
1.Tye B, Commins N, Ryazanova L, Wühr M, Springer M, Pincus D, Churchman S. Proteotoxicity from aberrant ribosome biogenesis compromises cell fitness. Elife. 2019;8. PMCID: PMC6453566 Reference Link